The goal of this study was to evaluate the morphology, immunoprofile, and management of renal oncocytoma (RO), hybrid oncocytic tumor (HOT), and chromophobe renal cell carcinoma (ChRCC).
Forty-seven cases of RO, 7 cases of HOT, and 25 cases of ChRCC were included in the study.